Kromek Group plc (GB:KMK) has released an update.
Kromek Group plc, a developer of radiation and bio-detection technology, anticipates surpassing market expectations with a record revenue for FY 2024, backed by strong performance in advanced imaging and CBRN detection segments. The company has seen an increase in commercial momentum, improved gross margins, and operational efficiencies, leading to a positive EBITDA that exceeds market forecasts. Full financial details are set to be disclosed in September 2024.
For further insights into GB:KMK stock, check out TipRanks’ Stock Analysis page.
